In acute coronary syndrome, intravascular ultrasound-guidance of PCI improved clinical outcomes safely and more effectively than angiography alone in the IVUS-ACS trial.
"Our study included all different kinds of complex lesions," Shao-Liang Chen, MD, of the Nanjing Medical University and Nanjing First Hospital, Nanjing, China, told attendees at theon April 8. The primary endpoint was the one-year composite of target vessel failure , including cardiac death, target vessel"We found that the TVF endpoint was 7.3% in the angiography-guided group compared to only 4.
The primary endpoint was TVF, a composite of cardiac death, TVMI, or clinically driven TVR, at 1 year after randomization. A primary endpoint event occurred in 70 patients in the IVUS group and 128 in the angiography group , largely driven by reductions in TVMI or TVR. "It is reassuring to see that there was no difference in effect sizes when stratified by types of ACS," said Gupta, who was not involved in the study. However, given that the study protocol was amended to allow for enrollment up to 30 days prior to ACS presentation,"it would be informative to know what proportion of patients were not included at the time of the index ACS," she said.
ACS - Acute Coronary Syndrome Acute Coronary Syndrome (ACS) Cardiovascular Imaging Cardiac Imaging CV Imaging Angiography Arteriography Interventional Cardiology Devices And/Or Drugs Interventional Cardiology Device Interventional Cardiology Drug Stent Drug-Eluting Stent Intravascular Ultrasound Thromboembolism Percutaneous Coronary Intervention PCI
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Telemedicine Reduces Rehospitalization, Revascularization in Post-PCI ACS PatientsA telemedicine program for patients with acute coronary syndrome discharged after percutaneous coronary intervention improved outcomes significantly compared with standard care.
Read more »
Remote Monitoring Protocol Reduces Hospital Readmission Rates After PCIResults of a new trial suggest that patients who participated in a remote monitoring protocol after PCI had a 76% lower rate of hospital readmission after 6 months compared to those who had standard post-discharge care. The TELE-ACS trial also showed lower rates of emergency department visits, unplanned coronary revascularizations, and cardiovascular symptoms for telemedicine patients. However, the rates of major adverse cardiovascular events were similar between the two groups.
Read more »
Ticagrelor Alone Cuts Bleeding Without More Events Post-PCITicagrelor monotherapy safely cut bleeding by more than half after intervention for acute coronary syndrome, without an increase in MACCE, in the ULTIMATE-DAPT trial.
Read more »
Withdrawal of Aspirin Post-PCI Reduces Major Bleeding by Over 50%High-risk heart patients on ticagrelor show improved outcomes and reduced bleeding by over 50% when aspirin is withdrawn one month after PCI, according to a study.
Read more »
Preventive PCI for Vulnerable Plaques Reduces Cardiac EventsPreventive PCI plus optimal medical therapy reduced cardiac events and death in patients with non–flow-limiting coronary plaques vs medical therapy.
Read more »
ACS Report: Nearly 10 Million Deaths from Cancer Worldwide in 2022The American Cancer Society (ACS) has released its latest report on global cancer statistics, revealing that nearly 10 million people died from cancer worldwide in 2022. The report highlights the importance of healthy lifestyle habits in preventing cancer, as almost 50% of cases are potentially preventable. The growing and aging population is also contributing to the increasing cancer rates. The report provides valuable insights and identifies potential areas for intervention.
Read more »